InsiderClue
Insiders · Profile

Foundation Fighting Blindness Retinal Degeneration Fund

Director at Opus Genetics. Filing since 9 Dec 2025. CIK 0002042266

Company
Date
Role
Action
Shares
Amount
Of holding
IRD Opus Genetics, Inc.
30 Sep 2026
Director
Sold at will
556,000
$2.76M
14.7%
IRD Opus Genetics, Inc.
18 May 2026
Director
Sold at will
1,700,000
$7.40M
31.0%
IRD Opus Genetics, Inc.
9 Dec 2025
Director
Sold at will
4,000,000
$8.60M
42.1%
3 decisions on file.